MorphoSys Quote - MOR

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

18.16

Bid

18.01

Ask

18.38

Volume

56,309

18.10 Day's Range 18.23

0.00 52 Week Range 0.00

Market Cap

10.809B

Previous Close

18.20

Open

18.20

Last Trade

834

18.16

Last Trade Time

15:00:00

Financial Volume

US$ 1,024,179

VWAP

18.1885

Average Volume (3m)

Shares Outstanding

150,620,548

Dividend Yield

PE Ratio

-56.97

Earnings Per Share (EPS)

-1.26

Revenue

238.28M

Net Profit

-189.73M

MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in di... MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Biolog/vaccines

Website

www.morphosys.com

Headquarters

Munich, Deu

Founded

1992

MorphoSys AG is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MOR. The last closing price for MorphoSys was US$18.20. Over the last year, MorphoSys shares have traded in a share price range of US$ 0.00 to US$ 0.00.

MorphoSys currently has 150,620,548 shares outstanding. The market capitalization of MorphoSys is US$10.81 billion. MorphoSys has a price to earnings ratio (PE ratio) of -56.97.

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis AG following the successful closing of the...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DNDelta 9 Cannabis Inc	$ 0.015 (50.00%)	1.1M
BRMIBoat Rocker Media Inc	$ 1.02 (29.11%)	1.84M
TSATTelesat Corporation	$ 12.50 (17.26%)	3.24k
QECQuesterre Energy Corporation	$ 0.25 (16.28%)	24.6k
GEOGeodrill Limited	$ 2.30 (15.58%)	47.28k
NCPNickel Creek Platinum Corp	$ 0.01 (-33.33%)	1.07k
LPENLoop Energy Inc	$ 0.025 (-28.57%)	73.62k
ASNDAscendant Resources Inc	$ 0.035 (-22.22%)	1,000
FLNTFlint Corporation	$ 0.025 (-16.67%)	16.5k
BNGBengal Energy Ltd	$ 0.03 (-14.29%)	85k
TRPTC Energy Corporation	$ 51.87 (-1.76%)	34.35M
BNSBank of Nova Scotia	$ 62.58 (0.29%)	18.9M
POWPower Corp of Canada	$ 38.02 (-1.66%)	13.19M
TDToronto Dominion Bank	$ 75.20 (0.09%)	9.87M
MFCManulife Financial Corporation	$ 36.44 (0.41%)	6.48M